Rimonabant: Weight Loss PLUS Smoking Cessation

Rimonabant (also known as Zimulti, Acomplia, Slimona or Obitone) is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Rimonabant has been found to stop food craving enough to help people lose weight, and could also help curb other unhealthy urges, such as smoking. This is a non-control weightloss solution that in one study, helped people who were overweight drop an average of 20 pounds, and was found to be very useful for patients who suffer from obesity.

November 5th, 2007: For all new orders for Rimonabant, please note that the name on the package is Slimona-Rimonabant / Obitone, which is the same as Rimonabant.

Manufacturer: Cadila, Zydus		Average Delivery Time: 12 Days
Sold Under Brand Name: Acomplia		Exp. Date: Approx. March 2009

	Rimonabant in the News Romonabant is quickly becoming a popular topic of conversation in the news. Check out these informative articles and videos! Watch this report from YouTube! Obesity pill now available in UK 'Miracle' Weight Loss Pill May Offer Obesity Cure Can Geneticists Cure Obesity? Super pill may fight obesity, addiction Drug boosts dieting weight loss

How does Rimonabant work?

• Rimonabant acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1
• Rimonabant switches off the same brain circuits that make people hungry when they smoke cannabis
• CB1 receptor blockade with Rimonabant acts to decrease the overactivity of the endocannabinoid system (EC system)2,3. The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.
  

What is Rimonabant used for?

• Rimonabant acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1
• Rimonabant switches off the same brain circuits that make people hungry when they smoke cannabis
• CB1 receptor blockade with Rimonabant acts to decrease the overactivity of the endocannabinoid system (EC system)2,3. The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.
  

Does Rimonabant also aid smoking cessation?

Clinical trials have shown that heavy smokers, after being on a regular supplement of Rimonabant, have stopped smoking altogether. Smokers usually do not stop smoking for fear of weight-gain, which can be highly discouraging. However since Rimonabant works on the overeating and smoking factors simultaneously such problems wouldn't arise

How Do I Use It?

View Medical Usage Directions for Rimonabant (requires Adobe Acrobat Reader)